Arousal Response Tool for Neurological Disease (ART_ND)
Parkinson Disease, Stroke, Healthy
About this trial
This is an interventional basic science trial for Parkinson Disease focused on measuring arousal, valence, emotion, heart rate variability, electrodermal activity, u-shape curve, performance, neurorehabilitation
Eligibility Criteria
Parkinson's disease Group
Inclusion criteria:
- Diagnosis of idiopathic Parkinson's Disease according to the UK Brain Bank Criteria
Exclusion criteria:
- Mini Mental State Examination < 24;
- Inability to walk without aid (Hoen & Yahr Scale >3)
Stroke Group
Inclusion criteria:
- Ischemic attack diagnosis.
Exclusion criteria:
- Mini Mental State Examination < 24;
- Inability to walk without aid.
Healthy Subject Group
Inclusion criteria:
- Age between 25 and 80;
- Absence of neurologic disease;
Exclusion criteria:
- Mini Mental State Examination < 24.
Sites / Locations
- Department of Neuroscience, University of Padua
- IRCCS San Camillo HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Parkinson's disease Group
Stroke Group
Healthy Subjects Group
The study envisages the recruitment of 45 subjects (see Sample Size on page 11), to be divided into 15 subjects per group. The groups will be formed by subjects diagnosed with Parkinson's and Stroke disease, for 50% men and 50% for women. The control subjects, on the other hand, will be neurologically healthy volunteers of equal age and scholarship and gender. All the groups will attend the same procedure and interventions: MS Band 2 , Rest, Emotion Assessment, Single Task, Dual Task .
The study envisages the recruitment of 45 subjects (see Sample Size on page 11), to be divided into 15 subjects per group. The groups will be formed by subjects diagnosed with Parkinson's and Stroke disease, for 50% men and 50% for women. The control subjects, on the other hand, will be neurologically healthy volunteers of equal age and scholarship and gender. All the groups will attend the same procedure and interventions: MS Band 2 , Rest, Emotion Assessment, Single Task, Dual Task .
The study envisages the recruitment of 45 subjects (see Sample Size on page 11), to be divided into 15 subjects per group. The groups will be formed by subjects diagnosed with Parkinson's and Stroke disease, for 50% men and 50% for women. The control subjects, on the other hand, will be neurologically healthy volunteers of equal age and scholarship and gender. All the groups will attend the same procedure and interventions: MS Band 2 , Rest, Emotion Assessment, Single Task, Dual Task .